Last updated on August 2019

A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy

Brief description of study

The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in subjects with moderately and severely active Crohn's disease (CD).

Clinical Study Identifier: NCT03345836

Find a site near you

Start Over

Advanced Research Institute /ID# 164814

New Port Richey, FL United States
  Connect »